(Q37528486)
Statements
Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing (English)
H A Yu
M E Arcila
M D Hellmann
M Ladanyi
scientific article published on February 2014